Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-05-09

Clinical Trial Update: Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating an escitalopram combination therapy for adults with major depressive disorder; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

Sponsor: Pharmacology Research Institute | Conditions: Major Depressive Disorder | Phase 3 | Status: UNKNOWN